NEUROLOGICAL SYMPTOMS AND ANTIPHOSPHOLIPID ANTIBODIES - IS NEUROLUPUS STILL A REALITY

被引:14
作者
HACHULLA, E
LEYS, D
DELEUME, JF
PRUVO, JP
DEVULDER, B
机构
来源
REVUE DE MEDECINE INTERNE | 1995年 / 16卷 / 02期
关键词
ANTIPHOSPHOLIPID ANTIBODY; CENTRAL NERVOUS SYSTEM INVOLVEMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; PRIMARY ANTIPHOSPHOLIPID ANTIBODIES;
D O I
10.1016/0248-8663(96)80676-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antiphospholipid antibody is associated with a clinical syndrome of vascular thrombosis, thrombocytopenia, recurrent fetal loss and livedo reticularis, whether or not a clinical diagnosis of systemic lupus erythematosus (SLE) coexists. Central nervous system involvement in SLE is multifactorial, thrombotic events, antineuronal antibodies, hypertension, infection, side effects of drugs etc. Antiphospholipid antibodies may play a role in focal neurological manifestations in SLE. In the absence of SLE, different neurological symptoms are well associated with antiphospholipid antibodies including stroke, seizures, dementia, migraine, ocular ischemia, chorea, transverse myelopathy, cerebral phelebitis. Other association are more controversal like Guillain Barre syndrome, motor neuron disease, communicating hydrocephalus. In all patients with antiphospholipid antibodies with neurological involvement, cerebral MRI may be performed with an echocardiographic study because a possible association with Libman and Sacks endocarditis, valve dysfunction or cardiac thrombus source of cerebral ischemia.
引用
收藏
页码:121 / 130
页数:10
相关论文
empty
未找到相关数据